Prostatis Group LLC lifted its stake in Goldman Sachs ActiveBeta Emerging Markets Equity ETF (NYSEARCA:GEM – Free Report) by 104.6% during the 2nd quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 32,539 shares of the company’s stock after purchasing an additional 16,638 shares during the period. Prostatis Group LLC’s holdings in Goldman Sachs ActiveBeta Emerging Markets Equity ETF were worth $1,211,000 at the end of the most recent quarter.
Other hedge funds and other institutional investors have also made changes to their positions in the company. Mengis Capital Management Inc. bought a new position in Goldman Sachs ActiveBeta Emerging Markets Equity ETF during the second quarter worth about $221,000. Consolidated Portfolio Review Corp bought a new position in Goldman Sachs ActiveBeta Emerging Markets Equity ETF during the 2nd quarter worth approximately $301,000. Truist Financial Corp boosted its stake in Goldman Sachs ActiveBeta Emerging Markets Equity ETF by 8.7% during the 2nd quarter. Truist Financial Corp now owns 23,996 shares of the company’s stock worth $893,000 after acquiring an additional 1,918 shares during the last quarter. Independence Bank of Kentucky bought a new position in Goldman Sachs ActiveBeta Emerging Markets Equity ETF during the 2nd quarter worth approximately $32,000. Finally, Destiny Wealth Partners LLC boosted its stake in Goldman Sachs ActiveBeta Emerging Markets Equity ETF by 3.3% during the 2nd quarter. Destiny Wealth Partners LLC now owns 163,880 shares of the company’s stock worth $6,098,000 after acquiring an additional 5,246 shares during the last quarter.
Goldman Sachs ActiveBeta Emerging Markets Equity ETF Price Performance
Goldman Sachs ActiveBeta Emerging Markets Equity ETF stock opened at $39.72 on Friday. Goldman Sachs ActiveBeta Emerging Markets Equity ETF has a fifty-two week low of $29.19 and a fifty-two week high of $41.62. The firm has a market capitalization of $1.11 billion, a price-to-earnings ratio of 13.33 and a beta of 0.72. The company’s 50 day simple moving average is $39.51 and its 200 day simple moving average is $36.60.
Goldman Sachs ActiveBeta Emerging Markets Equity ETF Profile
The Goldman Sachs ActiveBeta Emerging Markets Equity ETF (GEM) is an exchange-traded fund that mostly invests in total market equity. The fund tracks an index of emerging market stocks comprising 4 sub-indexes: value, momentum, quality, and low volatility. The index uses multiple factors to pick stocks, and each sub-index receives equal weight.
Recommended Stories
- Five stocks we like better than Goldman Sachs ActiveBeta Emerging Markets Equity ETF
- Stocks with Unusual Volume: How to Find Unusual Volume Stocks in Real Time
- Bassett Furniture: Buy Now, Sit Back, and Collect Dividends
- How to Most Effectively Use the MarketBeat Earnings Screener
- AST SpaceMobile’s Big Win: Shares Soar on New Deal With Verizon
- 3 Warren Buffett Stocks to Buy Now
- Catch the Next Bitcoin Rally With These 3 ETFs
Want to see what other hedge funds are holding GEM? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Goldman Sachs ActiveBeta Emerging Markets Equity ETF (NYSEARCA:GEM – Free Report).
Receive News & Ratings for Goldman Sachs ActiveBeta Emerging Markets Equity ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Goldman Sachs ActiveBeta Emerging Markets Equity ETF and related companies with MarketBeat.com's FREE daily email newsletter.